<p>巴港财富管理在第三季度削减了对礼来公司（NYSE:LLY - 免费报告）3.5% 的持股，具体情况在其最近向 SEC 的披露中提到。这家机构投资者在该期间出售了 2,647 股后，持有 72,327 股该公司的股票。礼来公司占巴港财富管理持股的 3.3%，是其第五大持股。根据巴港财富管理最近的 SEC 文件，礼来公司的持股价值为 55,186,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>礼来的新药数据为 2026 年设定了高风险局面</li>
</ul>
<p>其他一些大型投资者最近也买卖了该公司的股票。Braun Bostich &amp; Associates Inc.在第二季度将其对礼来公司的持股增加了 2.5%。Braun Bostich &amp; Associates Inc.现在拥有 527 股该公司的股票，价值 411,000 美元，在此期间又购买了 13 股。Rise Advisors LLC 在第二季度将其对礼来公司的持股提升了 1.8%。Rise Advisors LLC 现在拥有 732 股该公司的股票，价值 571,000 美元，在上个季度又购买了 13 股。Occidental Asset Management LLC 在第二季度将其在礼来公司的持股增加了 0.7%。Occidental Asset Management LLC 现在拥有 1,966 股该公司的股票，价值 1,533,000 美元，在上个季度又购买了 13 股。New Insight Wealth Advisors 在第二季度将其对礼来公司的持股增加了 3.4%。New Insight Wealth Advisors 现在拥有 394 股该公司的股票，价值 307,000 美元，在上个季度又购买了 13 股。最后，Dash Acquisitions Inc.在第二季度将其对礼来公司的持股增加了 2.8%。Dash Acquisitions Inc.现在拥有 485 股该公司的股票，价值 387,000 美元，在上个季度又购买了 13 股。机构投资者持有该公司 82.53% 的股票。</p>
<h2>华尔街分析师观点</h2>
<p>几家研究公司对 LLY 发表了评论。汇丰银行在 12 月 10 日的研究报告中重申了 “持有” 评级，并设定了 1,070.00 美元的目标价。大和资本市场在 12 月 16 日的研究报告中设定了 1,230.00 美元的目标价，并给予该公司 “买入” 评级。摩根士丹利在 11 月 24 日的研究报告中将礼来公司的目标价从 1,171.00 美元上调至 1,290.00 美元，并给予该公司 “增持” 评级。Leerink Partners 在 12 月 18 日的研究报告中重申了对礼来公司的 “跑赢大盘” 评级。最后，Wolfe Research 在 12 月 3 日的报告中将礼来公司的目标价从 1,050.00 美元上调至 1,250.00 美元，并给予该公司 “跑赢大盘” 评级。四位投资分析师对该股票给予了强烈买入评级，十七位给予了买入评级，五位给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
<ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
<p><strong>查看我们关于 LLY 的最新报告</strong></p>
<h2>礼来公司股价上涨 0.0%</h2>
<p>NYSE:LLY 周五开盘价为 1,077.26 美元。礼来公司的 12 个月低点为 623.78 美元，12 个月高点为 1,111.99 美元。该公司的 50 日简单移动平均为 986.75 美元，200 日简单移动平均为 841.14 美元。公司的流动比率为 1.55，速动比率为 1.24，债务与股本比率为 1.71。公司的市值为 1.02 万亿美元，市盈率为 52.70，市盈增长比率为 1.09，贝塔值为 0.37。</p>
<ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）在 10 月 30 日（星期四）发布了其财报。该公司报告每股收益（EPS）为 7.02 美元，超出市场共识预期的 6.42 美元，超出幅度为 0.60 美元。该公司在本季度的收入为 176 亿美元，而市场共识预期为 160.9 亿美元。礼来公司的股本回报率为 109.52%，净利润率为 30.99%。该公司的收入同比增长 53.9%。在去年同期，该公司每股收益为 1.18 美元。礼来公司已将其 2025 财年的指引设定为 23.000-23.700 的每股收益。平均而言，股票研究分析师预计礼来公司在本年度将发布 23.48 的每股收益。</p>
<h2>礼来公司增加股息</h2>
<p>该公司最近还披露了季度股息，将于 3 月 10 日（星期二）支付。记录在案的股东将在 2 月 13 日（星期五）获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这相当于每年 6.92 美元的股息，股息收益率为 0.6%。该股息的除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率目前为 33.86%。</p>
<h2>关于礼来公司</h2>
<p>（免费报告）</p>
<p>礼来公司 NYSE: LLY 是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将腾飞</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><strong>想看看其他对 LLY 感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com，获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>巴港财富管理在第三季度减少了对礼来的持股，降幅为 3.5%，目前持有 72,327 股，市值为 5,519 万美元，成为该公司的第五大持仓。其他投资者也调整了他们的持股。分析师对礼来的共识评级为 “适度买入”，目标价格为 1,155.36 美元。该公司最近的财报超出预期，每股收益为 7.02 美元，营收为 176 亿美元，同比增长 53.9%</p>

<p>Bar Harbor Wealth Management cut its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 3.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 72,327 shares of the company's stock after selling 2,647 shares during the period. Eli Lilly and Company accounts for 3.3% of Bar Harbor Wealth Management's holdings, making the stock its 5th biggest holding. Bar Harbor Wealth Management's holdings in Eli Lilly and Company were worth $55,186,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>巴港财富管理在第三季度削减了对礼来公司（NYSE:LLY - 免费报告）3.5% 的持股，具体情况在其最近向 SEC 的披露中提到。这家机构投资者在该期间出售了 2,647 股后，持有 72,327 股该公司的股票。礼来公司占巴港财富管理持股的 3.3%，是其第五大持股。根据巴港财富管理最近的 SEC 文件，礼来公司的持股价值为 55,186,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来的新药数据为 2026 年设定了高风险局面</li>
</ul>
</div><p>A number of other large investors also recently bought and sold shares of the business. Braun Bostich &amp; Associates Inc. increased its holdings in shares of Eli Lilly and Company by 2.5% in the 2nd quarter. Braun Bostich &amp; Associates Inc. now owns 527 shares of the company's stock valued at $411,000 after acquiring an additional 13 shares during the period. Rise Advisors LLC lifted its stake in shares of Eli Lilly and Company by 1.8% during the 2nd quarter. Rise Advisors LLC now owns 732 shares of the company's stock worth $571,000 after purchasing an additional 13 shares during the last quarter. Occidental Asset Management LLC boosted its position in Eli Lilly and Company by 0.7% during the second quarter. Occidental Asset Management LLC now owns 1,966 shares of the company's stock valued at $1,533,000 after purchasing an additional 13 shares in the last quarter. New Insight Wealth Advisors grew its stake in Eli Lilly and Company by 3.4% in the second quarter. New Insight Wealth Advisors now owns 394 shares of the company's stock valued at $307,000 after purchasing an additional 13 shares during the last quarter. Finally, Dash Acquisitions Inc. grew its stake in Eli Lilly and Company by 2.8% in the second quarter. Dash Acquisitions Inc. now owns 485 shares of the company's stock valued at $387,000 after purchasing an additional 13 shares during the last quarter. Institutional investors own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投资者最近也买卖了该公司的股票。Braun Bostich &amp; Associates Inc.在第二季度将其对礼来公司的持股增加了 2.5%。Braun Bostich &amp; Associates Inc.现在拥有 527 股该公司的股票，价值 411,000 美元，在此期间又购买了 13 股。Rise Advisors LLC 在第二季度将其对礼来公司的持股提升了 1.8%。Rise Advisors LLC 现在拥有 732 股该公司的股票，价值 571,000 美元，在上个季度又购买了 13 股。Occidental Asset Management LLC 在第二季度将其在礼来公司的持股增加了 0.7%。Occidental Asset Management LLC 现在拥有 1,966 股该公司的股票，价值 1,533,000 美元，在上个季度又购买了 13 股。New Insight Wealth Advisors 在第二季度将其对礼来公司的持股增加了 3.4%。New Insight Wealth Advisors 现在拥有 394 股该公司的股票，价值 307,000 美元，在上个季度又购买了 13 股。最后，Dash Acquisitions Inc.在第二季度将其对礼来公司的持股增加了 2.8%。Dash Acquisitions Inc.现在拥有 485 股该公司的股票，价值 387,000 美元，在上个季度又购买了 13 股。机构投资者持有该公司 82.53% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several research firms have commented on LLY. HSBC reissued a &#34;hold&#34; rating and set a $1,070.00 price target on shares of Eli Lilly and Company in a research report on Wednesday, December 10th. Daiwa Capital Markets set a $1,230.00 target price on shares of Eli Lilly and Company and gave the company a &#34;buy&#34; rating in a research report on Tuesday, December 16th. Morgan Stanley raised their target price on shares of Eli Lilly and Company from $1,171.00 to $1,290.00 and gave the company an &#34;overweight&#34; rating in a research note on Monday, November 24th. Leerink Partners reaffirmed an &#34;outperform&#34; rating on shares of Eli Lilly and Company in a research report on Thursday, December 18th. Finally, Wolfe Research increased their price objective on Eli Lilly and Company from $1,050.00 to $1,250.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, December 3rd. Four investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $1,155.36.</p>
<div class="lb-trans"><p>几家研究公司对 LLY 发表了评论。汇丰银行在 12 月 10 日的研究报告中重申了 “持有” 评级，并设定了 1,070.00 美元的目标价。大和资本市场在 12 月 16 日的研究报告中设定了 1,230.00 美元的目标价，并给予该公司 “买入” 评级。摩根士丹利在 11 月 24 日的研究报告中将礼来公司的目标价从 1,171.00 美元上调至 1,290.00 美元，并给予该公司 “增持” 评级。Leerink Partners 在 12 月 18 日的研究报告中重申了对礼来公司的 “跑赢大盘” 评级。最后，Wolfe Research 在 12 月 3 日的报告中将礼来公司的目标价从 1,050.00 美元上调至 1,250.00 美元，并给予该公司 “跑赢大盘” 评级。四位投资分析师对该股票给予了强烈买入评级，十七位给予了买入评级，五位给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 1,155.36 美元。</p>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的两个聪明资金动作</li>
</ul>
</div><p><strong>View Our Latest Report on LLY</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 LLY 的最新报告</strong></p>
</div><h2>Eli Lilly and Company Trading Up 0.0%</h2>
<div class="lb-trans"><h2>礼来公司股价上涨 0.0%</h2>
</div><p>NYSE:LLY opened at $1,077.26 on Friday. Eli Lilly and Company has a 12 month low of $623.78 and a 12 month high of $1,111.99. The firm has a fifty day simple moving average of $986.75 and a 200-day simple moving average of $841.14. The company has a current ratio of 1.55, a quick ratio of 1.24 and a debt-to-equity ratio of 1.71. The company has a market capitalization of $1.02 trillion, a P/E ratio of 52.70, a PEG ratio of 1.09 and a beta of 0.37.</p>
<div class="lb-trans"><p>NYSE:LLY 周五开盘价为 1,077.26 美元。礼来公司的 12 个月低点为 623.78 美元，12 个月高点为 1,111.99 美元。该公司的 50 日简单移动平均为 986.75 美元，200 日简单移动平均为 841.14 美元。公司的流动比率为 1.55，速动比率为 1.24，债务与股本比率为 1.71。公司的市值为 1.02 万亿美元，市盈率为 52.70，市盈增长比率为 1.09，贝塔值为 0.37。</p>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last released its earnings results on Thursday, October 30th. The company reported $7.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.42 by $0.60. The firm had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $16.09 billion. Eli Lilly and Company had a return on equity of 109.52% and a net margin of 30.99%.The firm's revenue was up 53.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.18 EPS. Eli Lilly and Company has set its FY 2025 guidance at 23.000-23.700 EPS. On average, equities research analysts anticipate that Eli Lilly and Company will post 23.48 earnings per share for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）在 10 月 30 日（星期四）发布了其财报。该公司报告每股收益（EPS）为 7.02 美元，超出市场共识预期的 6.42 美元，超出幅度为 0.60 美元。该公司在本季度的收入为 176 亿美元，而市场共识预期为 160.9 亿美元。礼来公司的股本回报率为 109.52%，净利润率为 30.99%。该公司的收入同比增长 53.9%。在去年同期，该公司每股收益为 1.18 美元。礼来公司已将其 2025 财年的指引设定为 23.000-23.700 的每股收益。平均而言，股票研究分析师预计礼来公司在本年度将发布 23.48 的每股收益。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Friday, February 13th will be issued a $1.73 dividend. This is a boost from Eli Lilly and Company's previous quarterly dividend of $1.50. This represents a $6.92 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, February 13th. Eli Lilly and Company's dividend payout ratio is currently 33.86%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，将于 3 月 10 日（星期二）支付。记录在案的股东将在 2 月 13 日（星期五）获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。这相当于每年 6.92 美元的股息，股息收益率为 0.6%。该股息的除息日期为 2 月 13 日（星期五）。礼来公司的股息支付比率目前为 33.86%。</p>
</div><h2>About Eli Lilly and Company</h2>
<div class="lb-trans"><h2>关于礼来公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company NYSE: LLY is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.</p>
<div class="lb-trans"><p>礼来公司 NYSE: LLY 是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将腾飞</li>
<li>有哪些费用可以从资本利得税中扣除？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 LLY 感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com，获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

礼来公司 $LLY 是巴尔港财富管理公司的第五大持仓